DekaBank Deutsche Girozentrale
BankPosition in CAI — Caris Life Sciences, Inc.
CIK 1456228
FRANKFURT, 2M
Position in CAI
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,603,502
-$8,766 QoQ
Shares Held
146,100
0.0% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#61
of 246 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CAI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DekaBank Deutsche Girozentrale holds $122,810,940 across 48 Biotechnology names. CAI ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BNTX |
BioNTech SE
|
481,397 | $44,793,990 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
113,193 | $34,074,488 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
280,330 | $16,040,482 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
100,000 | $7,448,000 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
93,807 | $7,437,957 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
8,000 | $4,295,600 | |
| 7 | CAI |
Caris Life Sciences, Inc.
This page
|
146,100 | $2,603,502 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
|
39,000 | $2,354,040 |
All Filings in CAI
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,603,502 | 146,100 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,612,268 | 146,100 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,941,778 | 146,100 | Shares | Sole | 2026-01-28 | |
| No filing history on record for this holder in this stock. | ||||||